ALADDIN
@aladdin_edu
Followers
125
Following
82
Media
72
Statuses
166
Educational program on strategic and regulatory science in paediatric oncology drug development. A project funded by the European Union’s Erasmus+ programme.
Joined September 2022
💡 Used the ALADDIN portal? Got 2 minutes? That’s all it takes to make a difference. Your feedback will help to drive better future editions of the #ALADDINProgramme. 📩 Survey closes soon: https://t.co/oMtUK15jE7
@ACCELERATE_cure @cci_europe @SKC_UK @SIOPEurope @ITCC_eu
forms.office.com
0
0
1
Don't miss your chance to have your say! Fill out the ALADDIN Portal survey to help us improve and guide what comes next. 🌟 🧞♂️Share your thoughts now: https://t.co/oMtUK15jE7
0
0
0
🙌 Thanks to everyone who’s shared feedback so far on the ALADDIN Portal! We’re still collecting input and your voice can help shape the future of the programme. 📝 Take the survey here: https://t.co/oMtUK15jE7
@ACCELERATE_cure
forms.office.com
0
0
0
🧞♂️ Have you used the ALADDIN online portal? We need your feedback! Help us shape the next edition of the #ALADDINProgramme 💡 📝 Take the quick survey now: https://t.co/oMtUK15jE7 Your voice matters! 🙌
1
0
0
🚀 New #ALADDINPodcast! In our 10th episode, host Sara Wakeling (Craddock) speaks with Dr. Ameeta Retzer & Dr. Victoria Forster about patient-reported outcomes & engagement in paediatric oncology research. 🎧Spotify: https://t.co/E35tzZEpeS 🎧Apple: https://t.co/WPR2tWOHGe
0
2
1
🔍 Spotlight on the ALADDIN Fellowship! This fully funded program with @ACCELERATE_cure allows professionals to take a deep dive into regulatory topics. Our 2nd Fellow, Sarah Al-Jilaihawi, is focused on the role of Patient-Reported Outcomes📝 Read more: https://t.co/GIsy2HIQuJ
0
1
1
The @ACCELERATE_cure conference was a fantastic platform to showcase the ALADDIN project. Huge congratulations to all the students and rotators who presented and participated! 👏 #PediatricOncology #DrugDevelopment #ALADDIN #EMA
0
0
0
A special moment for ALADDIN students! 🎓 Many attended the conference in person for the first time, gathering in Brussels to reflect on their experiences and discuss how they’ll apply their learning in the real world. 🌍
1
0
0
Later, Dr. Laura Fankhauser shared insights on Clinical Trial Assessments under the new Clinical Trial Regulation—contributing to ongoing efforts at @EMA_News to enhance medicine assessment for young patients. 🏥
1
0
0
🔎 Spotlight on ALADDIN 360 rotations! On Day 1, Dr. Erica Brivio presented her work as an ALADDIN Rotator at the @EMA_News, focusing on Paediatric Investigation Plans to improve medicine approval for children with cancer. 👏
1
0
0
🚀 Exciting updates from the ALADDIN team at the 10th annual @ACCELERATE_cure conference! A major event bringing together stakeholders to accelerate drug development for children & adolescents with cancer. 🧵⬇️ @cci_europe @SIOPEurope @SKC_UK @ITCC_eu
1
0
0
The latest episode of the ALADDIN podcast is here! This month, expert patient advocates Nick Bird, Nicole Scobie, and Antonia Palmer share their experiences of engaging in drug development research. Listen now on Spotify: https://t.co/wcGKQ4C7ud
0
3
3
The recently published paper, looks at the challenges that are faced when assessing new medicines for children’s cancers using a Paediatric Investigation Plan (PIP) Read the article here: https://t.co/7B21niEYch
@ACCELERATE_cure @cci_europe @SIOPEurope @ITCC_eu @prinsesmaximac
0
0
0
We are pleased to share the achievement of Erica Brivio who, alongside colleagues at @EMA_News , has authored an important new article in the EJC Paediatric Oncology Journal👏 Erica completed the ALADDIN 360 rotation programme last year. Read more here:
aladdin-education.eu
We are pleased to share the…
1
0
0
Team ALADDIN wishes you all a happy and peaceful festive season ⭐ It's been a busy year of delivering our educational programme on drug development for children's cancers, and we're looking forward to more of this in 2025 📅
0
0
0
Find out more about the process of approving new medicines for children with cancer on the ALADDIN portal:
0
0
0
For a new paediatric medicine to be approved across Europe, investigators must submit a Paediatric Investigation Plan (PIP). PIPs allow the @EMA_News to properly evaluate the data and evidence that has been found through clinical research. Take a look at the PIP process below👇
1
0
1
All episodes of the ALADDIN podcast are available on Spotify and Apple Podcasts. Listen here👂🔗
0
0
0
Earlier this year, we launched our very own podcast, inviting experts from the world of paediatric oncology to share their perspectives on the drug development pathway. Hosting the series is founder of @AlicesArc and parent advocate Sara Wakeling. Find out more about our host👇
1
0
0
Find out more about drug development for children with cancer on the ALADDIN portal:
0
0
0